Black Bird Biotech, Inc.
BBBT · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $4 | $13 | $7 | $12 |
| % Growth | -69.5% | 75% | -38.9% | – |
| Cost of Goods Sold | $3 | $6 | $4 | $11 |
| Gross Profit | $1 | $7 | $3 | $2 |
| % Margin | 36% | 54.1% | 45.8% | 12.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $11 | $100 | $78 | $114 |
| SG&A Expenses | $11 | $100 | $81 | $127 |
| Sales & Mktg Exp. | $0 | $0 | $3 | $13 |
| Other Operating Expenses | $1 | $0 | $1 | $1 |
| Operating Expenses | $12 | $101 | $86 | $128 |
| Operating Income | -$11 | -$94 | -$83 | -$127 |
| % Margin | -276.5% | -731.3% | -1,119.5% | -1,047.3% |
| Other Income/Exp. Net | -$120 | -$102 | -$184 | -$115 |
| Pre-Tax Income | -$131 | -$197 | -$267 | -$241 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$131 | -$197 | -$451 | -$241 |
| % Margin | -3,333.2% | -1,524.2% | -6,109.6% | -1,995.4% |
| EPS | -0 | -0 | -0.001 | -0.001 |
| % Growth | 66.7% | 70% | -25% | – |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 1,456,744 | 635,296 | 433,168 | 310,695 |
| Weighted Avg Shares Out Dil | 1,456,744 | 635,296 | 433,168 | 310,695 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $120 | $103 | $184 | $115 |
| Depreciation & Amortization | $52 | $1 | $1 | $1 |
| EBITDA | $42 | -$93 | -$82 | -$125 |
| % Margin | 1,059.3% | -721.7% | -1,104.3% | -1,036.8% |